Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Scientists are getting our robotic explorers ready to help send humans to Mars - 2Could the Star of Bethlehem have actually been a comet?
- 3Opening Achievement: 8 Methodologies for Compelling Using time productively
- 4NASA’s Artemis II launch leaves Americans in awe: ‘We’re going to the frickin’ moon!’
- 5'The Boys' Season 5 premiere: How to watch for less, what to know about the final series and more
- Remote Headphones: Upgrade Your Sound Insight
- Innospace's rocket crashes in first commercial launch in Brazil; shares tumble
- ‘RuPaul's Drag Race’ Season 18: How to watch without cable, premiere time, cast list and more
- Lula’s former human rights minister formally accused of sexual misconduct
- 4 Famous Gaming PCs of 2024: Execution, Versatility, and Advancement
- Lift Your Style: Famous Hairdos for Ladies
- ‘And then we saw the little head.’ Scientists witness rare sperm whale birth
- RFK Jr.'s vaccine panel delays hepatitis B shot vote after chaotic meeting
- Several Israelis attempt to cross into Gaza, escorted back to Israel by IDF
